Jessica Johnson, clinical consultant at Prime Therapeutics, shares how the Special Investigations Unit (SIU) helps prevent fraud, waste and abuse (FWA) in health care

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares tips to stay safe when using online pharmacies

Jessica Johnson, clinical consultant at Prime Therapeutics, shares more about common GLP-1 fraud schemes

Prime’s Special Investigations Unit is specially trained to protect patients and providers throughout the health care continuum

Care Management feature offers holistic assessment that helps support members by mitigating fraud, waste and abuse and patient safety concerns

When a member obtained diabetic supplies from 73 unique pharmacies and 53 prescribers, here’s how Prime worked closely with the insurance company to intervene

Jessica Johnson, clinical consultant at Prime Therapeutics, shares some ways to avoid common fraud schemes

Nationwide effort on April 26 offers opportunity to safely dispose of unused or expired medications

Jessica Johnson, clinical consultant at Prime Therapeutics, shares more about common fraud schemes in health care.

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares tips to identify fraud

Jessica Johnson, clinical consultant at Prime, shares some tips to stay safe

Jessica Johnson, clinical consultant at Prime/Magellan Rx’s special investigations unit, shares how to help lower the risk of drug misuse.

Lassen, chief clinical officer at Prime Therapeutics/Magellan Rx, shares insights on GLP-1 weight-loss drugs and evidence-based approaches to providing the kind of care we’d want for our loved ones.

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares tips to properly dispose of unused or expired medications

The SIU promotes safety to prevent fraud, waste and abuse schemes

Jessica Johnson, clinical consultant, shares how the Special Investigations Unit at Prime helps identify cases of fraud

Special Investigations Unit helps promote safety to prevent fraud, waste and abuse schemes

Experts share insights in “The evolving strategies for managing nAMD and DME” session at Las Vegas event

For the first time, Prime Therapeutics hosted the AMCP Nexus specialty keynote, addressing trends in cell and gene therapy and rare disease and immunology categories

Nicole Grevenitz, director of clinical account services, shares more from the research study “Promoting Health Equity Through Enhanced, Personalized Digital Outreach.”

Prime’s Sean Wuest and Highmark Health’s Lisanne Holley present educational session at Last Vegas event

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares how to identify fake GLP-1s

Lead author Kristin Brown-Gentry shares insights from the study “Unlocking Public Health Insights: Leveraging Air Quality Data to Develop Social Determinants of Health Metrics Linked to Asthma...

Prime's Sneha Sharma and Michael Szatkowski present “A beginner’s guide to decoding cell and gene therapy” educational session at event in Las Vegas, Nevada

Nick Friedlander, clinical program pharmacist at Prime, shares more about two research studies that convey the impact of one cost-savings solution.

Prime's Madhavi Manduru-Rao presents “Navigating the Final Chapter: What’s Next for Your Managed Care Pharmacy Career Journey – Opportunity for Rewirement vs. Retirement”

Brooke Hunter, senior health outcomes scientist at Prime, shares more about the study “Methodological Framework for Propensity Adjusted Benchmarks for Pharmacy Key Performance Indicators”

Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”

Jared Scripture, health outcomes scientist, shares more about the study “Leveraging Publicly Available SDOH Measures to Segment Members and Quantify Differences in Diabetic Medication Adherence: A...

Lead authors Erin Ventura and Alina Liang share more about the study “Evaluating the 10-Year Impact of an Immunoglobulin Utilization Management and Dose Optimization Program in the Managed Care...

Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”

As prescription opioid overdoses rise in the U.S., the Prime/MRx Special Investigations Unit (SIU) shares how to identify if someone has overdosed and how you can help save a life

Jessica Johnson, clinical consultant, shares how to identify and prevent opioid overdoses

Meredith Delk, senior vice president and general manager of state government solutions at Prime Therapeutics, shares more about the important role women play in our world today

A Q&A with Kristen Tveit, SVP, chief financial officer, Magellan Rx

Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service

One of the Prime Together Foundation’s 2023 grants went to TC Food Justice, which works to reduce food waste and hunger in the Twin Cities by linking those willing to help and those in need.

Prime Therapeutics residents, Almina Gomez and Kathryn Makay, shared their research and experiences at annual managed care pharmacy event 

How Prime Therapeutics/Magellan Rx Management reimagines pharmacy to do what's right.

Leading GLP-1 persistence, adherence and clinical outcomes research helps inform health plans and members